Abstract:Neuroprotective agents with attenuation of oxidative stress by directly scavenging ROS and indirectly through Keap1-Nrf2 signal pathway activation may be a promising cerebral ischemic stroke therapeutic strategy. In this study, a series of novel danshensu derivatives bearing pyrazolone moieties with dual antioxidant effects were synthesized for the treatment of ischemic stroke. Most compounds exhibited considerable DPPH free radical scavenging ability and neuroprotective activity against H2O2-induced oxidative injury in PC12 neuronal cells, without cytotoxicity. Among these target compounds, Del03 displayed the strongest dose-dependent neuroprotective activity in vitro, directly downregulated intracellular ROS levels, and improved the oxidative stress parameters MDA, SOD, and LDH. Del03 also promoted Nrf2 translocation to the nucleus, subsequently increasing the expression of the Nrf2 downstream target HO-1. Molecular docking analysis revealed that Del03 could anchor to the key site of Keap1. Del03 possessed the ability to penetrate blood-brain barrier and displayed good ability on pharmacokinetic properties in rats Del03 possessed good BBB penetration efficiency, suitable pharmacokinetic properties in vivo. Del03 reduced cerebral infarction volume and promoted neurological function in a middle cerebral artery occlusion (MCAO) mouse model at a dose of 20 mg/kg by intravenous injection. The characteristics of Del03 detailed in this study demonstrate its potential as a therapeutic agent in the treatment of ischemic stroke.

Discovery of a potential anti-ischemic stroke agent: 3-pentylbenzo[c]thiophen-1(3H)-one.

Discovery of 3-N-butyl-2,3-dihydro-1h-isoindol-1-one As A Potential Anti-Ischemic Stroke Agent

Synthesis of Novel 3-Butylphthalide Derivatives Containing Isopentenylphenol Moiety as Potential Antiplatelet Agents for the Treatment of Ischemic Stroke

Discovery of a Ring-Opened Derivative of 3-N-butylphthalide Bearing NO/H2S-donating Moieties As a Potential Anti-Ischemic Stroke Agent.

Design, Synthesis, and Biological Evaluation of Ligustrazine/resveratrol Hybrids As Potential Anti-Ischemic Stroke Agents.

Design, synthesis, and neuroprotective effects of novel hybrid compounds containing edaravone analogue and 3-<i>n</i>-butylphthalide ring-opened derivatives

Novel Hybrids of 3-N-butylphthalide and Edaravone: Design, Synthesis and Evaluations As Potential Anti-Ischemic Stroke Agents

Discovery of novel danshensu derivatives bearing pyrazolone moiety as potential anti-ischemic stroke agents with antioxidant activity

Discovery of neuroprotective Agents: Potent, brain Penetrating, lipoic acid derivatives for the potential treatment of ischemic stroke by regulating oxidative stress and inflammation - a Preliminary study

Novel Hybrids of Optically Active Ring-Opened 3-N-butylphthalide Derivative and Isosorbide As Potential Anti-Ischemic Stroke Agents.

Novel 2,6-Disubstituted Benzofuran-3-one Analogues Improve Cerebral Ischemia/reperfusion Injury Via Neuroprotective and Antioxidative Effects.

Enantiomers of 3-Pentylbenzo[c]thiophen-1(3h)-one: Preparation and Evaluation of Anti-Ischemic Stroke Activities

Design, Synthesis and Evaluation of Nitric Oxide Releasing Derivatives of 3-N-butylphthalide As Antiplatelet and Antithrombotic Agents.

Design, Synthesis, and Evaluation of NDGA Analogues As Potential Anti-Ischemic Stroke Agents.

Design, Synthesis And Biological Evaluation Of Hydrogen Sulfide Releasing Derivatives Of 3-N-Butylphthalide As Potential Antiplatelet And Antithrombotic Agents

Synthesis and Biological Evaluation of N-Butylphthalide Derivatives As Anti-Platelet Aggregation Agents

Design, Synthesis, and Biological Evaluation of Novel Tetramethylpyrazine- Nitrone Derivatives As Antioxidants

Novel multi-functional nitrones for treatment of ischemic stroke.

Design, Synthesis, and Biological Evaluation of Pierardine Derivatives As Novel Brain-Penetrant and in Vivo Potent NMDAR-GluN2B Antagonists for Ischemic Stroke Treatment.

Design, Synthesis, and Evaluation of the Novel Ozagrel-Paeonol Codrug with Antiplatelet Aggregation Activities As a Potent Anti-Stroke Therapeutic Agent

Design, synthesis and cardioprotective effect of a new class of dual-acting agents: Phenolic tetrahydro-β-carboline RGD peptidomimetic conjugates